参考文献/References:
1 郑钧正．从基因组学到放射组学的启示J．医学研究杂志，2016， 45：1-4．
2 Chen C, He M, Zhu Y, et al. Five critical elements to ensure the precision medicineJ. Cancer Metastasis Rev, 2015, 34: 313-318.
3 魏矿荣，彭侠彪，梁智恒，等．全球肝癌流行概况J．中国肿瘤，2015， 24：621-630．
4 Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012J. CA Cancer J Clin, 2015, 65: 87-108.
5 Forner A, Reig M, Bruix J. Hepatocellular carcinomaJ. Lancet, 2018, 391: 1301-1314.
6 中华人民共和国卫生和计划生育委员会医政医管局．原发性肝癌诊疗规范（2017年版）J．中华消化外科杂志， 2017， 16：635-647．
7 Friemel J, Frick L, Weber A. Intratumor heterogeneity in HCCJ. Aging （Albang NY）, 2015, 7: 350-351.
8 Lam A, Bui K, Hernandez Rangel E, et al. Radiogenomics and IRJ. J Vasc Interv Radiol, 2018, 29: 706-713.
9 Bedard PL, Hansen AR, Ratain MJ, et al. Tumor heterogeneity in the clinicJ. Nature, 2013, 501: 355-364.
10 Friemel J, Rechsteiner M, Frick L, et al. Intratumor heterogeneity in hepatocellular carcinomaJ. Clin Cancer Res, 2015, 21: 1951-1961.
11 徐?伟，李高峰，李?权，等．肝癌肿瘤异质性的临床新进展J．肝胆胰外科杂志， 2016， 28：84-86．
12 Kunihiko K, Sugihara S, Kojiro M. Relationship of histologic grade of hepatocellular carcinoma（HCC）to tumor size,and demonstration of tumor cells of multiple different grades in single small HCCJ. Liver, 1987, 7: 18-26.
13 An FQ, Matsuda M, Fujii H, et al. Tumor heterogeneity in small
hepatocellular carcinoma: analysis of tumor cell proliferation,expression and mutation of p53 AND beta-cateninJ. Int J Cancer, 2001, 93: 468-474.
14 Andreassen CN, Alsner J, Overgaard J. Does variability in normal tissue reactions after radiotherapy have a genetic basis: where and how to look for it?J. Radiother Oncol, 2002, 64: 131-140.
15 Baumann M, Holscher T, Begg AC. Towards genetic prediction of radiation responses: ESTROs GENEPI projectJ. Radiother Oncol, 2003, 69: 121-125.
16 Segal E, Sirlin CB, Ooi C, et al. Decoding global gene expression programs in liver cancer by noninvasive imagingJ. Nat Biotechnol, 2007, 25: 675-680.
17 Smith CP, Czarniecki M, Mehralivand S, et al. Radiomics and radiogenomics of prostate cancerJ. Abdom Radiol （NY）, 2019, 44:2021-2029.
18 Kuo MD, Jamshidi N. Behind the numbers: decoding molecular phenotypes with radiogenomics-guiding principles and technical considerationsJ. Radiology, 2014, 270: 320-325.
19 Kumar V, Gu Y, Basu S, et al. Radiomics: the process and the challengesJ. Magn Reson Imaging, 2012, 30: 1234-1248.
20 Court LE, Fave X, Mackin D, et al. Computational resources for radiomicsJ. Transl Cancer Res, 2016, 5: 340-348.
21 谢?凯，孙鸿飞，林?涛，等．影像组学中特征提取研究进展J．中国医学影像技术， 2017， 33：1792-1796．
22 Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are dataJ. Radiology, 2016, 278: 563-577.
23 Rios Velazquez E, Aerts HJ, Gu Y, et al. A semiautomatic CT-based ensemble segmentation of lung tumors: comparison with oncologists delineations and with the surgical specimenJ. Radiother Oncol, 2012, 105: 167-173.
24 Mukesh M, Benson R, Jena R, et al. Interobserver variation in clinical target volume and organs at risk segmentation in post-parotidectomy radiotherapy: can segmentation protocols help?J. Br J Radiol, 2012, 85: e530-e536.
25 Castellano G, Bonilha L, Li LM, et al. Texture analysis of medical imagesJ. Clin Radiol, 2004, 59: 1061-1069.
26 Seow P, Wong JHD, Ahmad-Annuar A, et al. Quantitative magnetic resonance imaging and radiogenomic biomarkers for gliomas characterisation: a systematic reviewJ. Br J Radiol, 2018, 91: 20170930.
27 Alessandrino F, Shinagare AB, Bosse D, et al. Radiogenomics in renal cell carcinomaJ. Abdom Radiol （NY）, 2019, 44:1990-1998.
28 Lü J, Zhang H, Ma J, et al. Comparison of CT radiogenomic and clinical characteristics between EGFR and KRAS mutations in lung adenocarcinomasJ. Clin Radiol, 2018, 73: 590.e1-590.e8.
29 Renzulli M, Buonfiglioli F, Conti F, et al. Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosisJ. Eur Radiol, 2018, 28: 506-513.
30 Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring systemJ. J Am Coll Surgeons, 2000, 191: 389-394.
31 Banerjee S, Wang DS, Kim HJ, et al. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinomaJ. Hepatology, 2015, 62: 792-800.
32 Renzulli M, Brocchi S, Cucchetti A, et al. Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma?J. Radiology, 2016, 279: 432-442.
33 Kuo MD, Yamamoto S. Next generation radiologic-pathologic correlation in oncology: Rad-Path 2.0J. Am J Roentgenol, 2011, 197: 990-997.
34 Peng J, Zhang J, Zhang Q, et al. A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinomaJ. Diagn Interv Radiol, 2018, 24: 121-127.
35 Bakr S, Echegaray S, Shah R, et al. Noninvasive radiomics signature based on quantitative analysis of computed tomography images as a surrogate for microvascular invasion in hepatocellular carcinoma: a pilot studyJ. J Med Imaging （Bellingham）, 2017, 4:041303.
36 Zhou Y, He L, Huang Y, et al. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinomaJ. Abdom Radiol （NY）, 2017, 42: 1695-1704.
37 朱海云，程永德，申宝忠．介入分子影像学研究进展J．介入放射学杂志， 2016， 25：1-6．
38 Kuo MD, Gollub J, Sirlin CB, et al. Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinomaJ. J Vasc Interv Radiol, 2007, 18: 821-831.
39 Park HJ, Kim JH, Choi SY, et al. Prediction of therapeutic response of hepatocellular carcinoma to transcatheter arterial chemoembolization based on pretherapeutic dynamic CT and textural findingsJ. Am J Roentgenol, 2017, 209: W211-W220.
40 Kwan SW, Fidelman N, Ma E, et al. Imaging predictors of response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiologic-pathologic correlationJ. Liver Transpl, 2012, 18: 727-736.
41 Lin M, Tian MM, Zhang WP, et al. Predictive values of diffusion-weighted imaging and perfusion-weighted imaging in evaluating the efficacy of transcatheter arterial chemoembolization for hepatocellular carcinomaJ. Onco Targets Ther, 2016, 9: 7029-7037.
42 Blanc-Durand P, Van Der Gucht A, Jreige M, et al. Signature of survival: a F-18-FDG PET based whole-liver radiomic analysis predicts survival after Y-90-TARE for hepatocellular carcinomaJ. Oncotarget, 2018, 9: 4549-4558.
相似文献/References:
[1]郭丽萍,张晓玲,王莉娜.经导管肝动脉化疗栓塞联合高强度聚焦超声治疗原发性肝癌的护理[J].介入放射学杂志,2010,(04):328.
GUO Liping,ZHANG Xiaoling,WANG Lina.The nursing care for patients of hepatocellular carcinoma treated with transcatheter hepatic arterial chemoembolization and high intensive focus ultrasound[J].journal interventional radiology,2010,(01):328.
[2]沈海洋,杨光,刘瑞宝,等.肝右叶前、后段原发性肝癌动脉化疗栓塞术后近期疗效比较[J].介入放射学杂志,2010,(05):382.
SHEN Haiyang,YANG Guang,LIU Ruibao,et al.Short－term effects of TACE for primary hepatocellular carcinoma of the right hepatic lobe：a comparison between the lesions in anterior segments and the lesions in posterior segments[J].journal interventional radiology,2010,(01):382.
[3]池嘉昌,沈加林,许建荣,等.全肝CT灌注成像在原发性肝癌TACE术后局部病灶活性评估中的临床应用[J].介入放射学杂志,2010,(07):540.
CHI Jiachang,SHEN Jialin,XU Jianrong,et al.Clinical application of whole－liver perfusion－enhanced CT imaging in evaluating the activity of residual hepatocellular carcinoma after TACE[J].journal interventional radiology,2010,(01):540.
[4]翁志成,杨维竹,江娜,等.CT引导下１２５I放射性粒子植入治疗肝癌门静脉癌栓的疗效评价[J].介入放射学杂志,2010,(07):535.
WENG Zhicheng,YANG Weizhu,JIANG Na,et al.Evaluation of CT－guided１２５I seed implantation combined with transcatheter arterial chemoem－bolization in treating portal vein tumor thrombus associated with hepatocellular carcinoma[J].journal interventional radiology,2010,(01):535.
[5]王悍 王精兵 张贵祥 王麟川.肝细胞癌动脉化疗栓塞术后并发脑梗死一例[J].介入放射学杂志,2005,(04):442.
WANG Han WANG Jing-bing ZHANG Gui-xiang WANG Lin-chuan.Cerebral infarction aften transaterial shemoembolization for hepatocellular carcinoma a cage report[J].journal interventional radiology,2005,(01):442.
[6]张绪敬,程佩芳,董光,等.原发性肝癌经导管化疗、栓塞前后血中凝血酶原变化的研究[J].介入放射学杂志,1992,(01):33.
[7]欧阳墉,马和平,张学军,等.肝细胞癌的鉴别诊断——附10例分析[J].介入放射学杂志,1996,(01):40.
[8]周斌,李征然,钱结胜,等.原发性肝癌肝移植后肿瘤复发的化疗栓塞治疗[J].介入放射学杂志,2009,(03):185.
ZHOU Bin,LI Zhengran,QIAN Jiesheng,et al.Chemoembolization for recurrent hepatocellular carcinoma after liver transplantation[J].journal interventional radiology,2009,(01):185.
[9]黄渊全,贾中芝,冯耀良,等.CT灌注成像在肝癌TACE术后疗效评价中的应用价值[J].介入放射学杂志,2009,(06):437.
HUANG Yuan-quan,JIA Zhong-zhi,FENG Yao-liang,et al.Clinical application of CT perfusion imaging in estimating the efficacy of transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma[J].journal interventional radiology,2009,(01):437.
[10]王惠文,刘瑞宝,刘 岩,等.原发性肝癌ＴＡＣＥ后ＦＡＫ、ＮＦκＢｐ６５表达及意义[J].介入放射学杂志,2011,(08):621.
WANG Hui-wen,LIU Rui-bao,LIU Yan,et al.The expression and significance of FAK and NF-κBp65 in hepatocellular carcinoma after transcatheter arterial chemoembolization[J].journal interventional radiology,2011,(01):621.